David Abrams's TEVA Position Overview
David Abrams (via Abrams Capital Management, L.P.) currently holds 6 M shares of Teva Pharmaceutical Industries Limited (TEVA) worth $0, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, David Abrams has maintained a long-term strategic position in TEVA, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2017, adding 19.06 M shares. Largest reduction occurred in Q1 2023, reducing 7.97 M shares.
Analysis based on 13F filings available since 2013 Q2
David Abrams's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by David Abrams
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +2.56 M | Add 0.00% | 2.56 M | $39.20 |
| Q3 2013 | -2.56 M | Sold Out | 2.56 M | $0.00 |
| Q3 2017 | +21.62 M | New Buy | 21.62 M | $17.60 |
| Q4 2017 | -1.88 M | Reduce 8.70% | 19.74 M | $18.95 |
| Q3 2018 | -220,751 | Reduce 1.12% | 19.52 M | $21.54 |
| Q4 2018 | -1 M | Reduce 5.12% | 18.52 M | $15.42 |
| Q1 2019 | -476,016 | Reduce 2.57% | 18.05 M | $15.68 |
| Q3 2019 | +6 M | Add 33.25% | 24.05 M | $6.88 |
| Q3 2022 | -147,060 | Reduce 0.61% | 23.9 M | $8.07 |
| Q4 2022 | -7.97 M | Reduce 33.33% | 15.93 M | $9.12 |
| Q1 2023 | -7.97 M | Reduce 50.00% | 7.97 M | $8.85 |
| Q4 2023 | -1.97 M | Reduce 24.72% | 6 M | $10.44 |
| Q1 2024 | -6 M | Sold Out | 6 M | $0.00 |
David Abrams's Teva Pharmaceutical Industries Limited Investment FAQs
David Abrams first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q2 2013, acquiring 2,561,269 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
David Abrams has held Teva Pharmaceutical Industries Limited (TEVA) for 44 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
David Abrams's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q3 2017, adding 21,623,886 shares worth $380.58 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q1 2024, David Abrams's firm, Abrams Capital Management, L.P., owns 5,996,836 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $0. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q1 2024 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 0.00% of David Abrams's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
David Abrams's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 24,046,356 shares, as reported at the end of Q3 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.